Display Settings:

Format

Send to:

Choose Destination
    Aging (Albany NY). 2011 Jul;3(7):685-91.

    Progeria, rapamycin and normal aging: recent breakthrough.

    Source

    Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. blagosklonny@oncotarget.com

    Abstract

    A recent discovery that rapamycin suppresses a pro-senescent phenotype in progeric cells not only suggests a non-toxic therapy for progeria but also implies its similarity with normal aging. For one, rapamycin is also known to suppress aging of regular human cells. Here I discuss four potential scenarios, comparing progeria with both normal and accelerated aging. This reveals further indications of rapamycin both for accelerated aging in obese and for progeria.

    PMID:
    21743107
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3181168
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 2
    Figure 1

      Supplemental Content

      Icon for Impact Journals, LLC Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk